about
Systemic corticosteroids for acute gout2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaThe genetics of hyperuricaemia and goutHyperuricaemia with deposition: latest evidence and therapeutic approachGout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort StudiesUric acid, hyperuricemia and vascular diseasesIncreased cardiovascular mortality associated with gout: a systematic review and meta-analysisUrate-lowering therapy for gout: focus on febuxostatImaging of gout: findings and utilityGout and the risk for incident heart failure and systolic dysfunction.Prescription and comorbidity screening following consultation for acute gout in primary care.Gout treatment and comorbidities: a retrospective cohort study in a large US managed care populationHyperuricemia and incident heart failure.Gout in primary care: Can we improve patient outcomes?The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study.Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort.Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment optionsHyperuricemia and the risk for subclinical coronary atherosclerosis--data from a prospective observational cohort study.The prevalence of hyperuricemia in China: a meta-analysis.Can racial disparities in optimal gout treatment be reduced? Evidence from a randomized trialAfrican American patients with gout: efficacy and safety of febuxostat vs allopurinol.The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age.Hyperthyroid and hypothyroid status was strongly associated with gout and weakly associated with hyperuricaemia.The association of gout with sleep disorders: a cross-sectional study in primary care.Febuxostat in the management of hyperuricemia and chronic gout: a review.Fructose-rich beverages and risk of gout in women.Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels.Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in TaiwanSerum urate is not associated with coronary artery calcification: the NHLBI Family Heart Study.Patients and providers view gout differently: a qualitative study.Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals.Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study.Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.Serum uric acid and cardiovascular disease.Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink.Rising burden of gout in the UK but continuing suboptimal management: a nationwide population studyModifiable risk factors for increased arterial stiffness in outpatient nephrologyComparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.
P2860
Q24243127-FAADF0A6-563E-4125-BE07-EA2A13556E44Q24612292-4C9B69DD-F85F-4ACB-9141-458D57E4B55FQ24629964-1CF72187-7CBC-414A-8D19-26E9C3456428Q26775759-D8C6DD62-F38C-4857-9EDB-3CEB08A7A746Q26800933-053B2005-C1F8-4088-AD47-19030CF400E8Q26850727-8F98FA0F-5673-4443-A884-F2762CC266AFQ27000643-102B70E5-CC67-43D3-B1D9-8981DD00E7A7Q28283310-B44DE3F9-50A7-4803-BB12-E5E5798FBB2FQ30484583-6B70811D-73A4-4CDD-A901-F17024D69F94Q30505423-BB4467CD-2026-44D2-8340-F00E8295BBB2Q30888155-D116E396-2E18-40AE-B89B-014E5A37234AQ31013182-E19403DE-A33D-4756-B814-6194F2DB206EQ33572047-40B05ECD-78A7-40A3-B1CD-247250AAAB2CQ33622431-8F1DFBC4-2562-4A01-A840-759241713E16Q33652892-5976DC3F-F602-4F31-94A8-F5F4A20FCA52Q33701688-C370BD59-4494-4071-B831-66431545C66FQ33864537-A21192B3-4FF7-4A15-A1AE-D28B6F7ECA4AQ33875877-ACE698C1-0DFB-4D12-B9DE-68C9F32DB09EQ34059953-BE602F6A-B519-4CAF-9727-DB527C75CAD1Q34153529-F70ADC43-5B30-4355-B552-48DCA9489692Q34153554-0599807E-FC1D-456F-B87C-C68FCD41B538Q34204854-9458E25A-11F8-4CB0-B01E-0C52743C1A3CQ34653781-D98498F5-7762-4D7E-BD2B-D137B4A45327Q34655021-73907477-7678-4F83-8671-09C9D8C44D0BQ34658300-C9D73F93-C1F9-4F21-808E-984FA9B7DDD0Q34684242-FDA0C0A7-3DB1-4675-9B7D-9ADD6356D5E4Q34734573-51AF8896-07E2-4D61-8AF7-78D4E07ED515Q35048342-704E1EDD-DF86-460D-8684-E39E72A75264Q35057848-3F85A769-6905-4EB4-834C-0BA5A8A72AB0Q35099038-C7EE3A12-1139-4933-8C21-AFEE9AC1F93FQ35102630-9F7CDF11-23AE-4FEB-BD58-71566ADA64B1Q35121532-70748053-4B25-474C-9AEA-23FE6645BDD7Q35126040-08E05A45-0369-4843-90F6-9B2564B6C323Q35166411-34719481-9585-4AED-8461-B52604D35942Q35225010-A981DC69-5889-4304-AC0C-412A22D763F2Q35306091-2247EB56-ABCF-47E4-9E3C-13BC1FD98D3EQ35352367-BFE1575F-75BB-4A8D-BFA5-8A3421D2B6C7Q35352449-43461D80-5539-4568-BD15-4446881E86E3Q35448958-ABC8F652-72E7-43F2-BA8B-D891EF6C3BB7Q35595259-1945AC63-B7C0-417C-A9BB-466378788A82
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Gout and the risk of acute myocardial infarction
@ast
Gout and the risk of acute myocardial infarction
@en
Gout and the risk of acute myocardial infarction
@nl
type
label
Gout and the risk of acute myocardial infarction
@ast
Gout and the risk of acute myocardial infarction
@en
Gout and the risk of acute myocardial infarction
@nl
prefLabel
Gout and the risk of acute myocardial infarction
@ast
Gout and the risk of acute myocardial infarction
@en
Gout and the risk of acute myocardial infarction
@nl
P2093
P3181
P356
P1476
Gout and the risk of acute myocardial infarction
@en
P2093
Daniel E Furst
Eswar Krishnan
H Ralph Schumacher
Joshua F Baker
P2860
P304
P3181
P356
10.1002/ART.22014
P407
P577
2006-08-01T00:00:00Z